Ignite Creation Date:
2025-12-26 @ 11:11 PM
Ignite Modification Date:
2026-02-24 @ 9:42 AM
Study NCT ID:
NCT03016312
Status:
COMPLETED
Last Update Posted:
2024-08-09
First Post:
2017-01-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-10
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-20
Completion Date Type:
ACTUAL
First Submit Date:
2017-01-09
First Submit QC Date:
None
Study First Post Date:
2017-01-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-04-05
Results First Submit QC Date:
None
Results First Post Date:
2021-04-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-08
Last Update Post Date:
2024-08-09
Last Update Post Date Type:
ACTUAL